2022_Oct_PDA_Universe_CA_leaderboard

Haselmeier

Haselmeier, the drug delivery device business division of medmix, designs, develops and manufactures user-friendly injection systems that enable patients to self-administer their medication reliably and accurately based on its proprietary IP and a broad portfolio of technologies and services.


Visit Website

Head Office
Haselmeier GmbH
Vaihinger Straße 48
70567 Stuttgart
Germany

Phone / Contact

T: +49 711 71978-0
E: info@haselmeier.com

Connect

Haselmeier, the drug delivery device business division of medmix, designs, develops and manufactures advanced drug delivery systems such as pen injection systems and autoinjectors, based on its proprietary IP (>200 patents granted with numerous further patents pending) and a broad portfolio of technologies and services. The company collaborates closely with pharma and biopharma customers, with a focus on delivering user-friendly injection systems that enable patients to self-administer their medication reliably and accurately.

Haselmeier was founded in 1920 and now has close to 250 employees. In October 2020, Haselmeier was acquired by Sulzer AG for an estimated €100 million. In 2021, Sulzer spun of its Applicator Systems (APS) division, which included Haselmeier, listed the new entity on the SIX Swiss stock exchange, and renamed it medmix.

medmix, with its precision injection moulding capabilities and expertise in liquid micro-dosing, plus financial strength and global footprint, helps Haselmeier accelerate innovation in healthcare.

Articles by Haselmeier

Top